Registry of Lobbyists
Organization: | Innovative Medicines Canada/Médicaments novateurs Canada |
Associated registration: | 782797-371-92 |
Communication date: | 2021-11-12 |
Posted date: | 2021-12-03 |
Designated Public Office Holders who participated in the communication: |
Dominic LeBlanc,
Minister of Intergovernmental Affairs, Infrastructure and Communities
House of Commons Kevin Lavigne, Minister’s Office Deputy Chief of Staff Privy Council Office (PCO) Brandan Rowe, Director of Strategic Planning Privy Council Office (PCO) |
Subject Matter of the communication: | Infrastructure, Science and Technology, Health, Regional Development, Industry |
Responsible Officer who filed this communication report: | Pamela Fralick |
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |